1) Erie JC, Nevitt MP, Hodge DO, Ballard DJ. Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol 1993;111:1665-71.
2) Thylefors B, Négrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ 1995;73:115-21.
3) Chirambo MC, Tielsch JM, West KP Jr, et al. Blindness and visual impairment in Southern Malawi. Bull World Health Organ 1986;64:567-72.
5) Brilliant LB, Pokhrel RP, Grasset NC, et al. Epidemiology of blindness in Nepal. Bull World Health Organ 1985;63:375-86.
6) Gilbert CE, Wood M, Waddel K, Foster A. Cause of childhood blindness in East Africa: results in 491 pupils attending 17 schools for the blind in Malawi, Kenya and Uganda. Ophthalmic Epidemiol 1995;2:77-84.
8) Khanal B, Deb M, Panda A, Sethi HS. Laboratory diagnosis in ulcerative keratitis. Ophthalmic Res 2005;37:123-7.
10) Zhang C, Liang Y, Deng S, et al. Distribution of bacterial keratitis and emerging resistance to antibiotics in China from 2001 to 2004. Clin Ophthalmol 2008;2:575-9.
11) Green M, Apel A, Stapleton F. A longitudinal study of trends in keratitis in Australia. Cornea 2008;27:33-9.
12) Hahn YH, Hahn TW, Tchah H, et al. Epidemiology of infectious keratitis(II): a multi-center study. J Korean Ophthalmol Soc 2001;42:247-65.
13) Kim JY, Yoon KC, Park YG, et al. Age-related clinical analysis of infectious keratitis in two tertiary centers. J Korean Ophthalmol Soc 2010;51:927-34.
14) Kim WJ, Kweon EY, Lee DW, et al. Prognostic factors and antibiotics susceptibility in bacterial keratitis: results of an eight-year period. J Korean Ophthalmol Soc 2009;50:1495-504.
15) Lim SH, Lee SB. Analysis of inpatients with bacterial keratitis over a 12-year period: pathogenic organisms and antibiotic resistance. J Korean Ophthalmol Soc 2012;53:372-84.
16) Kim MR, Lee SB. Clinical and microbiological analysis of gram-positive bacterial keratitis, a 15-year review. J Korean Ophthalmol Soc 2014;55:1432-44.
17) Cho EY, Lee SB. Gram-negative bacterial keratitis: a 15-year review of clinical aspects. J Korean Ophthalmol Soc 2015;56:1479-88.
18) Park MH, Yoo WS, Kim GN, et al. Clinical aspects of infectious keratitis in Western Gyeongsangnamdo, Republic of Korea. J Korean Ophthalmol Soc 2019;60:731-9.
19) Sun HJ, Lee JY, Kim SY, Jung MS. Clinical features of infectious keratitis in west coast area of Chungcheongnam-do, Korea. J Korean Ophthalmol Soc 2010;51:658-63.
21) Parmar P, Salman A, Kalavathy CM, et al. Microbial keratitis at extremes of age. Cornea 2006;25:153-8.
23) Mukerji N, Vajpayee R, Sharma N. Technique of area measurement of epithelial defects. Cornea 2003;22:549-51.
24) Biemer JJ. Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method. Ann Clin Lab Sci 1973;3:135-40.
25) Jorgensen JH, Hindler JF. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis 2007;44:280-6.
26) Van Der Meulen I, Van Rooij J, Nieuwendaal CP, et al. Age-related risk factors, culture outcomes, and prognosis in patients admitted with infectious keratitis to two Dutch tertiary referral centers. Cornea 2008;27:539-44.
27) Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J 1997;23:275-81.
28) Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis: predisposing factors and morbidity. Ophthalmology 2006;113:109-16.
30) Jones DB. Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears. Surv Ophthalmol 1979 24:97., 105-16.
31) Huang AJ, Wichiensin P, Yang MC. Bacterial keratitis. In: Krachmer JH, Mannis MJ, Holland EJ, ed. Cornea, 2nd ed. Philadelphia: Elsevier, 2005;v. 1. chap. 81.
32) Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea 2008;27:22-7.
33) Wright TM, Afshari NA. Microbial keratitis following corneal transplantation. Am J Ophthalmol 2006;142:1061-2.
34) Cheng KH, Leung SL, Hoekman HW, et al. Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet 1999;354:181-5.
35) Cho CH, Lee SB. Analysis of inpatients with contact lens related bacterial keratitis: causative microorganisms, clinical aspects, and prognostic factors. J Korean Ophthalmol Soc 2013;54:1327-38.
36) Lee KH, Chae HJ, Yoon KC. Analysis of risk factors for treatment failure in fungal keratitis. J Korean Ophthalmol Soc 2008;49:737-42.
37) Miedziak AI, Miller MR, Rapuano CJ, et al. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology 1999;106:1166-71.
38) Snyder M, Katz H. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol 1992;114:336-8.
39) Afshari N, Ma J, Duncan SM, et al. Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis. J Ocul Pharmacol Ther 2008;24:217-23.
40) Jhanji V, Sharma N, Satpathy G, Titiyal J. Fourth-generation fluoroquinolone-resistant bacterial keratitis. J Cataract Refract Surg 2007;33:1488-9.
41) Moshirfar M, Mirzaian G, Feiz V, Kang P. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refract Surg 2006;32:515-8.